Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO)

Q: What does CUSIP 71880W501 represent in this 13F holders report?

CUSIP 71880W501 is the security identifier for PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share in Q2 2025?

11 institutional investors reported PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 71880W501

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 12,067,869
Total 13F shares: 164,722
Share change: +64,104
Total reported value: $387,355
Price per share: $2.35
Number of holders: 11
Value change: +$164,978
Number of buys: 7
Number of sells: 4

Quarterly Holders Quick Answers

What is CUSIP 71880W501?
CUSIP 71880W501 identifies PHIO - Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 71880W501:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Institutional Holders of Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO) as of Q2 2025

As of 30 Jun 2025, Phio Pharmaceuticals Corp. - Common Stock, $0.0001 par value per share (PHIO) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 164,722 shares. The largest 10 holders included GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Cetera Investment Advisers, Virtu Financial LLC, MORGAN STANLEY, Royal Bank of Canada, SBI Securities Co., Ltd., ASSETMARK, INC, BANK OF AMERICA CORP /DE/, and ELEVATION POINT WEALTH PARTNERS, LLC. This page lists 11 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.